1H NMR-based metabolomics study on a goldfish model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Richard S. Burns, Chuang C. Chiueh, Sanford P. Markey et al. · Proceedings of the National Academy of Sciences · 1983 · 2.1K citations · Full text

Medicine, Neuroscience, Pharmacology +17

Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

Olaf Beckonert, Hector C. Keun, Timothy M. D. Ebbels et al. · Nature Protocols · 2007 · 2.1K citations

Life Sciences, Biochemistry, Pharmaceutical Analysis +17

Proton NMR chemical shifts and coupling constants for brain metabolites

Karl Young, Andrew A. Maudsley · NMR in Biomedicine · 2000 · 1.7K citations

Life Sciences, Biochemistry, Neuroscience +14

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Charles D. Smith, John M. Carney, Pamela Starke‐Reed et al. · Proceedings of the National Academy of Sciences · 1991 · 1.3K citations

Life Sciences, Neurobiology, Neuroscience +17

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

Richard E. Heikkila, Arthur Hess, Roger C. Duvoisin · Science · 1984 · 1K citations

Medicine, Neuroscience, Pharmacology +17